글번호
241546
작성일
2021.09.18
수정일
2021.09.19
작성자
김민걸
조회수
164

[제1저자] Influenza and anosmia: Important prediction factors for severity and death of COVID-19

Objectives To investigate the factors related to the severity and mo rtality of COVID-19 using big data-machine learning techniques. Methods This study included 8070 patients in South Korea diagnosed with COVID-19 between January and July 2020, and whose data were available from the National-Health-Insurance-Service. Results Machine-learning algorithms were performed to evaluate the effects of comorbidities on severity and mortality of COVID-19. The most common comorbidities of COVID-19 were pulmonary inflammation followed by hypertension. The model that best predicted severity was a neural network (AUC: 85.06%). The most important variable for predicting severity in the neural network model was a history of influenza (relative importance: 0.083). The model that best predicted mortality was the logistic regression elastic net (EN) model (AUC: 93.86%). The most important variables for mortality in the EN model were age (coefficient: 2.136) and anosmia (coefficient: -1.438). Conclusions In COVID-19 patients, influenza was found to be a major adverse factor in addition to old age and male. In addition, anosmia was found to be a major factor associated with lower severity and mortality. Therefore, in the current situation where there is no adequate COVID-19 treatment at present, examining the patient's history of influenza vaccination and anosmia in addition to age and sex will be an important indicator for predicting the severity and mortality of COVID-19 patients.

Keywords: COVID 19; Comorbidities; Machine learning; Modeling; Mortality; SARS-CoV-2; Severity.
Title
Influenza and anosmia: Important prediction factors for severity and death of COVID-19
Author
Doo Hwan Kim, Min Gul Kim, Seong J Yang, Eun Jung Lee, Sang Woo Yeom, Yeon Seok You, Jong Seung Kim
Year
2021
Journal
J Infect
Details
2021 Aug 19;S0163-4453(21)00413-8
DOI
10.1016/j.jinf.2021.08.024
첨부파일
다음글
다음글이(가) 없습니다.
이전글
[교신저자] Pharmacokinetics of a New, Once-Daily, Sustained-Release Pregabalin Tablet in Healthy Male Volunteers
김민걸 2021-09-18 23:47:08.0